Modern Healthcare Technology Holdings Limited (FRA:M3L)
Germany · Delayed Price · Currency is EUR 0.0075
+0.0005 (7.14%)
Last updated: Jan 28, 2026, 10:30 AM CET
FRA:M3L Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 451.7 | 453.27 | 454.71 | 406.33 | 355.59 | 431.45 |
Other Revenue | 2.76 | 2.78 | 2.73 | 2.81 | 1.94 | 2.01 |
| 454.46 | 456.05 | 457.43 | 409.13 | 357.53 | 433.46 | |
Revenue Growth (YoY) | -3.46% | -0.30% | 11.80% | 14.43% | -17.52% | -17.40% |
Cost of Revenue | 287.16 | 305.65 | 308.78 | 290.74 | 269.73 | 197.94 |
Gross Profit | 167.3 | 150.4 | 148.65 | 118.4 | 87.8 | 235.52 |
Selling, General & Admin | 13.88 | 14.16 | 16.34 | 15 | 14.82 | 15.33 |
Other Operating Expenses | 33.77 | 35.46 | 40.02 | 36.61 | 40.03 | 37.14 |
Operating Expenses | 122.59 | 125.3 | 133 | 138.84 | 145.81 | 159.54 |
Operating Income | 44.7 | 25.1 | 15.66 | -20.45 | -58.01 | 75.98 |
Interest Expense | -3.59 | -4.47 | -5.92 | -1.77 | -2.1 | -3.56 |
Interest & Investment Income | 4.4 | 4.82 | 4.14 | 0.89 | 0.12 | 0.73 |
Other Non Operating Income (Expenses) | -24.24 | -24.86 | -22.72 | -17.19 | -16.73 | -12.71 |
EBT Excluding Unusual Items | 21.28 | 0.59 | -8.84 | -38.52 | -76.72 | 60.44 |
Impairment of Goodwill | - | - | - | - | - | -1.07 |
Gain (Loss) on Sale of Assets | - | 0.09 | 4.95 | 0.27 | 0.36 | -0.59 |
Asset Writedown | -2.93 | -5.5 | -5.8 | -5.49 | 7.2 | 0.54 |
Other Unusual Items | - | - | - | 25.45 | 2.49 | 70.71 |
Pretax Income | 20.13 | -3.04 | -9.59 | -18.29 | -66.66 | 130.03 |
Income Tax Expense | 1.83 | 1.73 | -0.96 | 1.84 | 2.04 | 6.1 |
Earnings From Continuing Operations | 18.3 | -4.77 | -8.63 | -20.13 | -68.7 | 123.93 |
Minority Interest in Earnings | -0.52 | -0.3 | -0.95 | -0.48 | -0.1 | 1.79 |
Net Income | 17.78 | -5.07 | -9.57 | -20.61 | -68.81 | 125.72 |
Net Income to Common | 17.78 | -5.07 | -9.57 | -20.61 | -68.81 | 125.72 |
Net Income Growth | 507.03% | - | - | - | - | - |
Shares Outstanding (Basic) | 904 | 904 | 904 | 904 | 904 | 904 |
Shares Outstanding (Diluted) | 904 | 904 | 904 | 904 | 904 | 904 |
EPS (Basic) | 0.02 | -0.01 | -0.01 | -0.02 | -0.08 | 0.14 |
EPS (Diluted) | 0.02 | -0.01 | -0.01 | -0.02 | -0.08 | 0.14 |
EPS Growth | 512.66% | - | - | - | - | - |
Free Cash Flow | 153.7 | 134.94 | 64.08 | 125.52 | -29.55 | 121.65 |
Free Cash Flow Per Share | 0.17 | 0.15 | 0.07 | 0.14 | -0.03 | 0.13 |
Gross Margin | 36.81% | 32.98% | 32.50% | 28.94% | 24.56% | 54.34% |
Operating Margin | 9.84% | 5.50% | 3.42% | -5.00% | -16.23% | 17.53% |
Profit Margin | 3.91% | -1.11% | -2.09% | -5.04% | -19.25% | 29.00% |
Free Cash Flow Margin | 33.82% | 29.59% | 14.01% | 30.68% | -8.26% | 28.06% |
EBITDA | 57.07 | 36.28 | 23.36 | -7.58 | -42.23 | 101.85 |
EBITDA Margin | 12.56% | 7.96% | 5.11% | -1.85% | -11.81% | 23.50% |
D&A For EBITDA | 12.37 | 11.18 | 7.71 | 12.87 | 15.78 | 25.87 |
EBIT | 44.7 | 25.1 | 15.66 | -20.45 | -58.01 | 75.98 |
EBIT Margin | 9.84% | 5.50% | 3.42% | -5.00% | -16.23% | 17.53% |
Effective Tax Rate | 9.07% | - | - | - | - | 4.69% |
Advertising Expenses | - | 2.58 | 4.21 | 3.05 | 3.11 | 2.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.